Abstract:Introduction Late Life Depression (LLD) is characterized by low remission rates using currently available treatments. Therefore, it is crucial for clinicians to have personalized tools to better identify older adults who may have a greater chance of success when deciding on a given treatment. In particular, psychotherapy is an important and under-utilized treatment option for older adults who may not tolerate medications or have drug interactions that limit pharmacotherapy. In this study, we aimed to use machine-learning methods to identify pre-treatment characteristics that are predictive of psychotherapy treatment success (i.e. Depression Remission after psychotherapy treatment). Methods We analyzed data from a previously described 12-week trial of weekly Problem Solving Therapy (PST) in 96 participants with Major Depressive Disorder who were 65 years or older (Kassel et al. 2022). Using machine-learning methods, we examined 20 pre-treatment characteristics of interest across four categories: 1) Demographic Factors, 2) Depression History, 3) Depression Symptom Characteristics, and 4) Cognitive Test Scores. The Gradient Boosted Method (GBM) was used to determine the relative importance of each characteristic as a possible predictor, which guided development of specific, short (depth=3) Decision Tree models to predict Depression Remission (17-item Hamilton Depression Score < 7). Given sample size limitations, these models were trained on the same sample to which they were applied for prediction. Results Three Decision Tree models were significant at the p<0.001 threshold: Age and Depression History, pre-treatment Episodic Memory Function, and All 20 Pre-treatment Characteristics Available (the resulting optimal model only utilized 5 of the 20 characteristics across the 4 categories of available pre-treatment characteristics). Amongst the three significant models: Classification Accuracy was 73.6-77.4% and AUC was 0.763-0.789. These 3 models offered high Specificity (82.8-95.1%) and Negative Predictive Value (75.3-82.8%) and relatively lower Sensitivity (34.5-63.3%) and Positive Predictive Value (61.5-76.9%). Age and Depression History (See Figure 1) was the simplest of the three significant models with only five Leaves (i.e. Terminal Nodes). In contrast, models derived from the pre-treatment Cognitive Domains of Executive Function, Processing Speed, and Language Function were each not significantly predictive of Depression Remission at the p<0.001 threshold. Models derived from pre-treatment Depression Symptom Characteristics were also not significantly predictive at this threshold. Conclusions We have derived an Age and Depression History Decision Tree model (Figure 1) that would only require assessment of 3 simple pre-treatment characteristics to improve prediction of psychotherapy success: correctly classifying about three quarters of the participants in our sample. The pre-treatment Episodic Memory Function Decision Tree model had a similar classification rate but does require cognitive testing. Both models were superior to models derived only from other Cognitive Domains, including models of Executive Function. However, validation of these models is needed and will require testing their predictive value in larger, more representative samples. These results demonstrate a novel machine-learning based prediction strategy that is simple for clinicians to use and thus may hold promise in personalizing difficult treatment decisions for LLD.

Optimizing precision medicine for second-step depression treatment: a machine learning approach

Prediction of Antidepressant Treatment Response and Remission Using an Ensemble Machine Learning Framework

Cross-trial prediction of depression remission using problem-solving therapy: A machine learning approach

Combining machine learning algorithms for prediction of antidepressant treatment response

Validation of Machine Learning-Based Individualized Treatment for Depressive Disorder Using Target Trial Emulation

Machine learning to predict clinical remission in depressed patients after acute phase selective serotonin reuptake inhibitor treatment

Ensemble Learning for Early‐Response Prediction of Antidepressant Treatment in Major Depressive Disorder

Using Machine Learning to Predict Antidepressant Treatment Outcome from Electronic Health Records

Predicting remission after acute phase pharmacotherapy in patients with bipolar I depression: A machine learning approach with cross‐trial and cross‐drug replication

Machine learning in the prediction of depression treatment outcomes: a systematic review and meta-analysis

Predicting treatment outcome in depression: an introduction into current concepts and challenges

Examining factors related to low performance of predicting remission in participants with major depressive disorder using neuroimaging data and other clinical features

Development of a differential treatment selection model for depression on consolidated and transformed clinical trial datasets

Development and Validation of a Deep-Learning Model for Differential Treatment Benefit Prediction for Adults with Major Depressive Disorder Deployed in the Artificial Intelligence in Depression Medication Enhancement (AIDME) Study

Subphenotyping Depression Using Machine Learning and Electronic Health Records

Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial

Machine Learning Prediction of Treatment Outcome in Late-Life Depression

Developing Clinically Relevant Decision Tree Models Using Machine-Learning to Predict Psychotherapy Success in Late Life Depression

Data-driven personalized medicine approaches to cognitive-behavioral therapy allocation in a large sample: A reanalysis of the ENRICHED study

Computational approaches to treatment response prediction in major depression using brain activity and behavioral data: A systematic review

Reinforcement learning processes as forecasters of depression remission